Dr. Linda Rabeneck, a physician, clinician scientist and health care executive, is Vice President, Prevention and Cancer Control at Cancer Care Ontario, Professor of Medicine and Professor, Dalla Lana School of Public Health at the University of Toronto, and Senior Scientist at the Institute for Clinical Evaluative Sciences (ICES) in Toronto.
Dr. Rabeneck received her MD from the University of British Columbia (UBC), followed by post-graduate training in Internal Medicine and Gastroenterology at UBC and the University of Toronto. She received her Master’s degree in Public Health (MPH) from Yale University, where she trained as a Robert Wood Johnson Clinical Scholar.
Dr. Rabeneck, whose scholarly work involves the evaluation of health care interventions and health system performance, is best known for her research on the quality and effectiveness of colorectal cancer screening. She has authored approximately 230 peer reviewed publications.
Dr. Rabeneck played a leadership role in the launch of ColonCancerCheck in Ontario, Canada’s first organized, province-wide colorectal cancer screening program. Under her leadership, Ontario was also the first province in Canada to launch an organized screening program for women at high risk of breast cancer and to launch a pilot of organized lung screening for persons at high risk of the disease.
Dr. Rabeneck is Chair, Colorectal Cancer Screening Committee of the World Endoscopy Organization (WEO), Associate Editor of Gastroenterology, Master of the American College of Gastroenterology (ACG), recipient of the ACG’s Berk/Fise Clinical Achievement Award, and recipient of UBC’s Medical Alumni Association Wallace Wilson Leadership Award. Dr. Rabeneck was elected President of the Canadian Academy of Health Sciences in 2017.